|
|
|
2008 Neurotech Leaders Forum
October 23-24, 2008
Radisson Hotel San Francisco Airport, Brisbane, CA
Tentative Agenda
Day One: Neurotech Basics
The first day of the 2008 event is devoted to basic information about the neurotechnology industry, targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. Conference faculty will offer a detailed background on the basics of the neurotechnolgy industry. The afternoon offers a novel session on neuropharmaceuical therapies and concludes with a panel discussion of issues affecting end users in the neurological disorders community.
| 8:30-9:00 |
Registration and Coffee |
| 9:00-10:30 |
Neuroengineering History and Basics
Daniel DiLorenzo, M.D., Ph.D., President, DiLorenzo Biomedical
In this session, Dan DiLorenzo, a leading expert on neurotechnology, will present a tutorial on the fundamentals of neurostimulation, neuromodulation, deep-brain stimulation, and related topics. The tutorial will begin with a history of neurostimulation and explain how neurotech devices work, and include a discussion of product features, stimulation parameters, targeted locations. |
| 10:30-10:45 |
Refreshment Break |
| 10:45-12:15 |
Neurotechnology Market Overview
James Cavuoto, Editor and Publisher, Neurotech Reports
This session gives attendees an overview of the neurotechnology device market, with discussion of overall size, market segments, growth rates, competition, and key players. It will also include discussion of the various markets for neurological diseases and disorders. |
| 12:15-1:45 |
Luncheon |
| 1:45-3:15 |
Neuropharma Market Overview
Glenn Cornett, Ph.D, M.D., Senior Financial Editor, Neurotech Reports
This session offers a brief overview of the neuropharmaceutical industry and introduces some of the key players in the market. It also explores potential partnerships between neurotech device and drug companies. |
| 3:15-3:30 |
Refreshment Break |
| 3:30-5:00 |
Obtaining Venture Capital Financing
Glenn Cornett, Ph.D, M.D., Senior Financial Editor, Neurotech Reports
This session offers specific and practical advice on preparing a set of initial materials, including executive summary, investor presentation, and financial model, that will attract attention from venture capital firms. It includes examples of items that have made the difference between funding and no funding decisions. The presenter will also discuss how to find the most appropriate VC firm and how to arrange a meeting with the key person at the firm. |
| 5:00-7:00 |
Cocktail Reception
|
| |
|
Day Two: Neurotech Industry Sessions
The second day of the conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to grow this new industry.
| 8:30-9:00 |
Registration and Coffee |
| 9:00-9:15 |
Introduction |
| 9:15-9:45 |
Keynote Address
|
| 9:45-10:15 |
Neurotechnology Industry Update
James Cavuoto, Editor and Publisher, Neurotech Reports
This session will provide attendees with an up-to-date look at the neurotechnology industry, including discussion of deals, merger and acquisition activity, and venture capital funding that has occurred in the last year. |
| 10:15-10:30 |
Coffee Break, sponsored by BalSeal Engineering
|
| 10:30-11:15 |
Neuromodulation Industry Issues
Glenn Cornett, M.D., Ph.D., Senior Financial Editor, Neurotech Reports, Moderator
Ben Pless, Ph.D., President, Autonomic Technologies, Inc.
Elliot Krames, M.D., President, International Neuromodulation Society
This session will cover many of the key issues facing the neuromodulation devices industry today, including reimbursement problems, distribution strategies, and the product approval process.
|
| 11:15-12:15 |
Technology Transfer Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Geoff Thrope, President and CEO, NDI Medical Inc.
This session looks at issues involved with spinning off neurotech startups from academic and clinical research laboratories. Panelists will offer examples of successful spinoffs and debate the advantages and disadvantages of alternative incentive, licensing, and financing options. |
| 12:15-1:30 |
Luncheon
Presentation of 2008 Gold Electrode Awards |
| 1:30-3:00 |
Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Ranu Jung, Ph.D., CEO, Advensys LLC
Keith Checca, Texcel Medical
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
| 3:00-3:15 |
Refreshment Break, Sponsored by Greatbatch, Inc. |
| 3:15-4:00 |
New Applications Panel
Dominique Durand, Ph.D., Professor of Biomedical Engineering,
Case Western Reserve University
This session looks at several new application areas emerging in neurotechnology and explores the commercialization potential of each. New technologies covered include optical stimulation, new neurosensing techniques, magnetic stimulation, and slow-wave stimulation. |
| 4:00-5:00 |
Investment Panel
Glenn Cornett, Ph.D., M.D., Senior Financial Editor, Neurotech Reports, Moderator
Karen Boezi, Partner, Thomas McNerney & Partners
Robert Abrams, Operating Partner, Sanderling Ventures
In this wrap-up session, representatives from several key venture capital firms in the life sciences space will offer their feedback on the status of the neurotechnology industry and their impressions of the issues discussed during the day. |
| 5:00-7:00 |
Cocktail Reception |
| |
|
|
